Adam Kaplin

Adam Kaplin

No open positions remaining
59 year
Consumer Services
Health Technology
Health Services

Profile

Adam Kaplin was the founder of MIRA Pharmaceuticals, Inc., founded in 2020, where the title held was President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also the founder of Nousynapse Pharmaceuticals..
Dr. Kaplin is currently the Director-Johns Hopkins Ketamine Clinic at The Johns Hopkins University since 2002.
Dr. Kaplin is also currently the Director at Cody Unser First Step Foundation since 2005.
Formerly, Dr. Kaplin was Chief Scientific Officer at Q from 2020 to 2024.
Education includes a doctorate from The Johns Hopkins University conferred in 1996 and an undergraduate degree from Yale University conferred in 1988.

Adam Kaplin active positions

CompaniesPositionStart
Corporate Officer/Principal 01/01/2002
Director/Board Member 01/01/2005

Former positions of Adam Kaplin

CompaniesPositionEnd
Q/C TECHNOLOGIES, INC. Chief Tech/Sci/R&D Officer 15/04/2024
MIRA PHARMACEUTICALS, INC. Founder 07/03/2024
See the detail of Adam Kaplin's experience

Training of Adam Kaplin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!